Radiation Recall Reaction Induced by Adjuvant Trastuzumab (Herceptin)
Although concerns of radiation sensitization have been raised with concurrent trastuzumab (Herceptin) administration, there has been no published case of radiation recall reaction associated with trastuzumab. This case describes a clinical presentation consistent with a radiation recall reaction fol...
Saved in:
| Main Authors: | Caroline Chung, David Stuart, Mira Keyes |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2009-01-01
|
| Series: | Case Reports in Medicine |
| Online Access: | http://dx.doi.org/10.1155/2009/307894 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative Preclinical Evaluation of Tuznue Versus Referent Herceptin: A Registered Trastuzumab Biosimilar
by: Herve Bischoff, et al.
Published: (2025-04-01) -
Validation of ELISA Test-system for Trastuzumab (Herceptin, Hertikad) quantitative determination in biological fluids
by: V. V. Pisarev, et al.
Published: (2023-05-01) -
Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance
by: Jin Jiang, et al.
Published: (2022-01-01) -
Corrigendum to “Herceptin-Mediated Cardiotoxicity: Assessment by Cardiovascular Magnetic Resonance”
Published: (2025-01-01) -
A Double-blind Randomized Comparative Phase I Study to Assess Biosimilarity and Immunogenicity of "Trastuzumab" (LLC "Mabscale", Russia) and Herceptin® (F. Hoffmann-La Roche Ltd., Switzerland) in Healthy Volunteers
by: M. A. Kolganova, et al.
Published: (2023-09-01)